.jpeg){kind=spacer}
After the discovery of diethylene glycol (DEG) in some cough syrups, the Central Drugs Standard Control Organisation (CDSCO) has launched a digitally monitored system on the Online National Drug Licensing System (ONDLS) portal.
GSK plc revealed that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a green signal to the approval of a new prefilled syringe presentation for Shingrix
Takeda Pharmaceutical Company and Innovent Biologics have orchestrated a global strategic alliance worth as much as $11.4 billion to expedite the creation of cutting-edge oncology drugs for solid tumors.
Torrent Pharmaceuticals, one of the top Indian pharmaceutical companies, is going to make a significant financial move after getting the green light from the regulatory body for its acquisition of JB Chemicals & Pharmaceuticals.
Xavier School of Management, Jamshedpur, was the venue of a distinguished leadership session with Jacob Jacob, Group Chief Human Resources Officer of Aster DM Healthcare, Dubai, as part of the Aster NextGen Management
The Union Ministry of Health and Family Welfare has suggested a significant modification of the Drugs Rules 1945, which would require Quick Response codes (QR)on labels of all medicines - vaccines, antimicrobials, anticancer, narcotic and...
AbbVie Inc. has fully acquired Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin, which represents a major expansion of AbbVie's neuroscience pipeline.
Dr Reddy's Laboratories Ltd reports that it has obtained an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations manufacturing plant (FTO 11) in Srikakulam, Andhra Pradesh...
Boston Scientific Corporation announced a definitive agreement to acquire Nalu Medical, Inc., a privately held medtech company that develops minimally invasive solutions for chronic pain management.
Merck's Phase 3 HIV trial highlights expertise in antiviral science, authority in clinical research, and advancing effective treatments showing minimal metabolic impact and reaffirming Merck's commitment to evidence-based HIV care
.jpg)
.jpg)
, CDSCO.jpg)